Category Archives: Renu

Featured Stories

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

A Port Jefferson Station man was killed on Wednesday due to a single-vehicle crash on the Northern State Parkway in Dix Hills. Police are investigating the accident, Newsday reports. According to Newsday, the 81-year-old man was driving a Nissan Altima west in the right lane, west of Exit 42. He ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Exposure to Common Pesticide May Increase ADHD Risk

Exposure to Common Pesticide May Increase ADHD Risk

A new study has found that exposure to a common household pesticide may increase the risk of attention deficit hyperactivity disorder (ADHD) in children.

Read More

Motion Seeks to Have Court Consider New Renu with MoistureLoc Evidence

New evidence shows that Renu with MoistureLoc Contact Lens Solution when heated in plastic containers loses antimicrobial qualities and can lead to varying forms of bacterial infections. The national law firm of Parker Waichman LLP, in light of this evidence, … Continue reading

Posted in Pharmaceuticals, Renu | Tagged , |

Evaporation of Contact Lens Solution Reduces Effectiveness

Partially evaporated contact lens solution loses much of its disinfectant ability, according to a new study. Many contact lens wearers unwittingly use partially evaporated solution, which can occur when contact lens wearers reuse solution or fail to recap their lens … Continue reading

Posted in Renu |

Bausch & Lomb Loses ReNu with MoistureLoc Insurance Case

Bausch & Lomb has lost another round in the legal wrangling involving its recalled < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc Contact Lens Solution. Last week, a federal judge ruled in favor of one of Bausch & Lomb’s insurers, Lexington Co., making it … Continue reading

Posted in Pharmaceuticals, Renu |

Multipurpose Contact Lens Solutions May Cause Eye Damage

Recent studies on some multipurpose contact lens solutions have found that such preparations can cause eye damage. One such study was detailed last week at the 8th National Congress on Optometry and Opticianry held in New York. Multipurpose contact lens … Continue reading

Posted in Pharmaceuticals, Renu |

Discovery Continues in ALL Pending ReNu with MoistureLoc Lawsuits

Lawsuits filed by people who claim they sustained non-Fusarium eye infections from Bausch & Lomb’s < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc Contact Lens Solution suffered a setback last month when a New York state court judge issued a ruling that excluded the … Continue reading

Posted in Pharmaceuticals, Renu |

Company Refocuses Marketing Efforts on ReNu

We recently wrote that Bausch & Lomb, maker of ReNu with MoistureLoc, settled around 600 lawsuits involving the < "http://www.yourlawyer.com/practice_areas/defective_drugs">recalled contact lens solution. Now, Bausch & Lomb is focusing on ReNu marketing. According to a prior report in the Associated … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Renu, Toxic Substances |

Hundreds of ReNu with MoistureLoc Lawsuits Settled

Bausch & Lomb, the maker of < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc, has settled around 600 lawsuits involving the recalled contact lens solution. According to a report in the Associated Press, the settled ReNu with MoistureLoc claims have so far cost the … Continue reading

Posted in Renu |

ReNu with MoistureLoc Lost Antifungal Properties When Exposed to High Temperatures

< "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc loses much of its ability to fight fungal contamination when exposed to high temperatures for a long period of time, according to a new study published in the Archives of Ophthalmology.  ReNu with MoistureLoc was recalled … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Tainted ReNu, AMO Contact Lens Solutions Prompt FDA Panel to Call for Better Testing

In the past several years, contact lens solutions, including < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc and < "http://www.yourlawyer.com/topics/overview/amo_complete_moisture_plus">Advanced Medical Optics Complete MoisturePlus, have been linked to potentially blinding eye infections. Now, a group of Food & Drug Administration (FDA) advisors has recommended … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Renu with MoistureLoc, Other Contact Lens Solution Recalls Result in FDA Safety Review

Contact lens solutions have been slated for a Food & Drug Administration (FDA) safety review.  The FDA decided to embark on the review after some popular brands of contact lens solutions – including < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">Renu with MoistureLoc – were linked … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

© 2005-2020 Parker Waichman LLP ®. All Rights Reserved.